Article Details

Acepodia Announces FDA Clearance of IND Application for ACE1831, an Anti-CD20 Armed ...

Retrieved on: 2022-06-20 12:07:54

Tags for this article:

Click the tags to see associated articles and topics

Acepodia Announces FDA Clearance of IND Application for ACE1831, an Anti-CD20 Armed .... View article details on hiswai:

Excerpt

and TAIPEI, Taiwan, June 20, 2022 /PRNewswire/ -- Acepodia, a clinical-stage biotechnology company developing first-in-class cell therapies with its ...

Article found on: en.prnasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up